send to a friend by email
2017-08-14
According to the financial statements of Jerusalem Pharmaceuticals for the first half of 2017, Net profit after tax of the period reached 3,026,907 USD Compared with Net profit after tax 759,186 USD for 2016, a net increase in profit of 298.70%.Total assets of the company reached 59,079,372 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 11.53%.Total liabilities of the company reached 14,582,336 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 14.73%. Net ownership equity of the company reached 44,497,036 USD (Including Non-Controlling Interests of 493,861 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 10.52%.
|
|